Objective: The aim of this study was to determine the DNA and genotypes of Echinococcus granulosus in liver cyst hydatids isolated in humans. Material and Methods: This study was conducted prospectively at the Department of General Surgery of the Cerrahpaşa School of Medicine, University of İstanbul-Cerrahpaşa, between January 2015 and June 2016 in 30 patients who were operated on for cystic Echinococcosis. E. granulosus DNA was analyzed using the Polymerase Chain Reaction (PCR) method in the cyst samples (protoscolex and/or germinative membrane) obtained during the operation, and genotype was determined in the PCR positive samples by sequence analysis. At the same time, indirect hemagglutination (IHA) was used to test for the presence of antibodies in the patients’ blood. Results:E. granulosus DNA was found in 29 out of 30 cystic Echinococcosis of the liver samples. All of the 29 cystic Echinococcosis samples were found to be G1 (sheep) species. Also, IHA was positive in 22 patients and negative in eight patients. Conclusion: In the present study, G1 species was the most commonly seen liver cystic Echinococcosis species. We suggest that a vaccine, which could be developed against prevalent regional genotypes, would be efficacious in the prevention of the disease with a cause of mortality and morbidity.
13 June 2022 in Infectious Diseases and Clinical Microbiology
Despite the decrease in incidence after having widespread vaccination programs, the COVID-19 pandemic continues to cause high morbidity and mortality in the world in its second year. Especially elderly people (over 65 years old), people with underlying health conditions, and healthcare workers (HCWs) are still at high risk for COVID-19 disease. Since […]
6 September 2022 in Eurasian Econometrics, Statistics & Emprical Economics Journal
Bu çalışmanın amacı, Ege bölgesinin tüm illerinde(İzmir, Aydın, Muğla, Uşak, Denizli, Manisa, Kütahya, Afyonkarahisar), halkın hayvansal kökenli besinlerin tüketim profillerini belirlemek ve tüketim al ışkanlıklarının hayvansal kökenli besinlerin (süt ve ürünleri, et ve ürünleri, su ürünleri, kanatlı eti ve kanatlı eti ürünleri) mikrobiyolojik kalitesine etkili olup olmadığının belirlenmesi ve bu ilişkilerin istatistik modellemeler içerisinde ortaya kona rak tüketim alışkanlıkları ile ürün hijyeni ve halk sağlığı arasındaki korelasyon ilişkilerinin ortaya konması olmuştur. Bu amaçla toplam 1600 adet hane ziyaret edilmiş ve hayvansal kökenli besinler ile ilgili sorular sorulmuştur. Her bir haneden bir adet ilgili besin örneği alınmış ve alınan örnekler toplam 3 adet mikrobiyolojik parametre açısından analiz edilmiştir. Elde edilen verilere göre; Ege bölgesindeki tüketicilerin demografik özellikleri ve hayvansal besin tüketim alışkanlıklarının, tükettikleri b esinlerin hijyeni ile yakından ilişkili olduğu belirlenmiştir.
This study aimed to assess the humoral immune response following administration of a BNT162b2 mRNA COVID‐19 booster dose and to evaluate its association with the development of SARS‐CoV‐2 infection after vaccination. Between July 2021 and February 2022, serum samples were collected from 313 individuals 28 days after receiving a COVID‐19 booster dose. Quantitative SARS‐CoV‐2 IgG antibodies directed against the receptor‐binding domain (RBD) of the spike protein were measured using a chemiluminescent microparticle immunoassay. Neutralizing antibody activity, defined as inhibition of the RBD–ACE2 interaction, was evaluated semi‐quantitatively by a competitive ELISA. Participants were followed for 6 months after the final dose to identify confirmed SARS‐CoV‐2 infections. The cohort included 97 males (31%) and 216 females (69%), with a mean age of 39.43 years. The median SARS‐CoV‐2 IgG antibody level at day 28 was 7713.3 AU/mL, and the median neutralizing antibody inhibition rate was 99.2%. Antibody levels were not significantly associated with age or comorbidities. Booster vaccination induced a strong humoral immune response in all participants. However, the occurrence of post‐vaccination infections despite high antibody levels suggests immune escape by emerging variants. While vaccines may not fully prevent infection, they provide substantial protection against severe disease and mortality.